SEC Comment Letter 0000000000-24-005444 to Axe Compute Inc. (AGPU)
Axe Compute Inc.
Date: May 13, 2024 · CIK: 0001446159 · Accession: 0000000000-24-005444
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279123
Letter
United States securities and exchange commission logo May 13, 2024 Raymond Vennare Chief Executive Officer Predictive Oncology Inc. 91 43rd Street, Suite 110 Pittsburgh, Pennsylvania 15201 Re:Predictive Oncology Inc. Registration Statement on Form S-3 Filed May 6, 2024 File No. 333-279123 Dear Raymond Vennare: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jane Park at 202-551-7439 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Alan Seem, Esq.
Show Raw Text
United States securities and exchange commission logo
May 13, 2024
Raymond Vennare
Chief Executive Officer
Predictive Oncology Inc.
91 43rd Street, Suite 110
Pittsburgh, Pennsylvania 15201
Re:Predictive Oncology Inc.
Registration Statement on Form S-3
Filed May 6, 2024
File No. 333-279123
Dear Raymond Vennare:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jane Park at 202-551-7439 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Alan Seem, Esq.